Epstein Secrets

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula E

kil Beshir Ulrich L. Bettermann Erik Behermann Jeffrey L. Bewkes Donald S. Beyer Homi K. Bhabha Neera

nnual Meeting EFTA_R1_02011009 EFTA02686135 Dariusz Jacek Krawiec John Krenicki Nicholas D. Kristof Patrick Kron Fred Krupp Andre Kudelski Michael Kuhndt Peter Kukielski Timur Kulibayev Ellen Kullman Manu Kumar Howard Kunreuther Rolf Kuntz Vera Kurochkina Kiyoshi Kurokawa Tapio Kuula Nabil R.

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

enry R. Kravis Dariusz Jacek Krawiec John Krenicki Jr Nicholas D. Kristof Neelie Kroes Patrick Kron Fred Krupp Andre Kudelski Aleksey Kudrin Michael Kuhndt Peter Kukielski Timur Kulibayev Ellen Kullman Manu Kumar Howard Kunreuther Rolf Kuntz Vera Kurochkina Haruhiko Kuroda Vice-President, Europe

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

enry R. Kravis Dariusz Jacek Krawiec John Krenicki Jr Nicholas D. Kristof Neelie Kroes Patrick Kron Fred Krupp Andre Kudelski Aleksey Kudrin Michael Kuhndt Peter Kukielski Timur Kulibayev Ellen Kullman Manu Kumar Howard Kunreuther Rolf Kuntz Vera Kurochkina Haruhiko Kuroda Vice-President, Europe

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula Esco

s Henry R. Kravis Dariusz Jacek Krawiec John Krenicki Jr Nicholas D. Kristof Neelie Kroes Patrick Kron Fred Krupp André Kudelski Aleksey Kudrin Michael Kuhndt Peter Kukielski Timur Kulibayev Ellen Kullman Manu Kumar Howard Kunreuther Rolf Kuntz Vera Kurochkina Haruhiko Kuroda Vice-President, European P